Apr 30 2021 Read 7 Times
The Ulkox® and Oleoabrax® products, based on an Olea Europaea leaf extract wound-healing technology, have been acquired by Noventure, specialised in licensing medical devices and food supplements. The medical devices were originally developed by Spanish companies Quesper R&D and Orpea Ibérica, together with the Andalusian Health Service (Servicio Andaluz de Salud, SAS).
Luciano Conde, CEO of Noventure, said: “This agreement will enable us to keep shaping innovative science assets and bring them to markets around the world, and to take steps towards becoming a key player in medical devices for topical applications. This is only the beginning; we have many innovative products that we will be able to bring to patients, thanks to this patented new technology.”
Barcelona, Spain, April 19,
2021 – Noventure, specialized in licensing innovative substance-based medical devices and specialist food supplements, today announces it has acquired the Ulkox® and Oleoabrax® products, based on an Olea Europaea leaf extract wound-healing technology. These medical devices were originally developed by Spanish companies Quesper R&D, specialising in the creation and development of medical devices with a markedly innovative character, and Orpea Ibérica, the leading company in Spain in the fields of care for the elderly and dependent people, and the mental health sector, together with the Andalusian Health Service (Servicio Andaluz de Salud, SAS)
.
Olea Europaea (olive) leaf extract has shown excellent scavenging effects which contribute to the acceleration of the healing of skin wounds. Chronic wounds are mostly seen in the elderly population. Increasing costs of health care, an aging population, recognition of difficult-to-treat infection threat